首页 › 基金 › Affinity Asset Advisors, LLC › CGEM

Affinity Asset Advisors, LLC 对 CGEM 的持仓历史

CULLINAN THERAPEUTICS INC · 医疗保健

Affinity Asset Advisors, LLC 在 Q3 2026 的 13F 申报中披露持有 CGEM(CULLINAN THERAPEUTICS INC)875,760 股,市值约 US$13.4M,约占其申报组合的 0.63%,在其申报持仓中市值排名第 39 位。 Affinity Asset Advisors, LLC 最近 12 个申报季度中有 12 个季度披露了 CGEM 持仓,最早可追溯至 Q4 2023。

最新持仓 (Q3 2026)875.76K 股
申报持仓市值$13.44M
组合权重0.63%
首次申报Q4 2023
最近变动持有
更新于2026-11-14

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

Affinity Asset Advisors, LLC 对 CGEM 的持仓演变

Affinity Asset Advisors, LLC 于 Q4 2023 首次披露 CGEM 持仓:300,000 股(约 US$3.1M)。 该持仓在 Q4 2025 达到峰值 1,932,106 股,市值约 US$20.0M。 在 12 次申报中,Affinity Asset Advisors, LLC 3 次增持、2 次减持、6 次保持不变。 最近一期申报(Q3 2026)显示持股 875,760 股、市值约 US$13.4M。 持仓曾出现大幅变动:Q4 2025 增持约 632% (随后一个季度股价上涨 37%)、Q1 2026 减持约 60% (随后一个季度股价上涨 28%)。

逐季持仓明细

季度股数金额变化
Q4 2023 300.00K $3.06M 新进
Q1 2024 258.59K $4.41M 减持
Q2 2024 263.82K $4.60M 增持
Q3 2024 263.82K $4.42M 持有
Q4 2024 263.82K $3.21M 持有
Q1 2025 263.82K $2.00M 持有
Q2 2025 263.82K $1.99M 持有
Q3 2025 263.82K $1.56M 持有
Q4 2025 1.93M $20.00M 增持
Q1 2026 781.26K $11.10M 减持
Q2 2026 875.76K $15.95M 增持
Q3 2026 875.76K $13.44M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 CGEM 与 13F 数据

CGEM(CULLINAN THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 33 只申报持有 CGEM,申报仓位最大的包括:MPM BioImpact LLC (US$177.2M), Lynx1 Capital Management LP (US$163.2M), BVF INC/IL (US$104.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 CGEM 的基金

查看 CGEM 的全部基金持有人 →

常见问题

How long has Affinity Asset Advisors, LLC held CGEM?

Affinity Asset Advisors, LLC has disclosed CGEM holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is Affinity Asset Advisors, LLC's current position in CGEM?

As of Q3 2026, Affinity Asset Advisors, LLC holds 875.76K shares of CGEM (CULLINAN THERAPEUTICS INC), valued at $13.44M, representing 0.63% of its reported portfolio and ranking #39.

Has Affinity Asset Advisors, LLC been buying or selling CGEM?

In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC held unchanged its position in CGEM. The position peaked in Q4 2025 at 1.93M shares.

Which other funds hold CGEM?

Other major institutional holders of CGEM include MPM BioImpact LLC, Lynx1 Capital Management LP, BVF INC/IL, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.